# Impact of substrate choice on human osteoclast differentiation and secretome: Implications for targeted therapeutic development

**Authors:** Fernanda D’Amélio, Hugo Vigerelli, Rodrigo Pinheiros Araldi, Adriana da Costa Neves, Álvaro Rossan de Brandão Prieto-da-Silva, Daniel Pimenta, Irina Kerkis

PMC · DOI: 10.1371/journal.pone.0333180 · PLOS One · 2025-10-17

## TL;DR

This study shows how the surface on which osteoclasts grow affects their protein profiles and function, offering new insights into bone-related therapies.

## Contribution

The study identifies substrate-specific proteomic profiles and novel therapeutic targets in polarized osteoclasts.

## Key findings

- Mineralized surfaces promote bone resorption-related proteins like lysosomal enzymes and ion transporters.
- Plastic substrates enrich pathways for adhesion and stress response, indicating a maintenance-focused phenotype.
- Key therapeutic targets include Hedgehog pathway components and regulators like NCOR2, NOS1, and XIAP.

## Abstract

Osteoclasts (OCs) exhibit substrate-specific molecular adaptations crucial for bone remodeling. We utilized mass spectrometry and functional enrichment analysis to delineate the proteomic profiles of mature polarized OCs cultured on mineralized versus plastic plates. Our findings reveal that mineralized surfaces promote the expression of proteins specialized for bone resorption and matrix interaction, such as lysosomal enzymes and ion transporters. This environment induces a mature and resorptive phenotype in OCs, enriched in pathways like VEGF/VEGFR signaling and various cytokine pathways. Conversely, OCs on plastic plates display a more diverse proteomic profile, highlighting adaptations in adhesion, proliferation, and stress response pathways, suggesting a focus on cellular maintenance rather than active resorption. Key therapeutic targets for osteoclastogenesis include components of the Hedgehog (Hh) pathway—SHH, DHH, and IHH—with Smoothened (SMO) integral to Hh signaling in OC differentiation. Additionally, Guanine Nucleotide Exchange Factors (GEFs), significantly enriched on plastic plates, are crucial for adapting to non-mineralized environments. Other notable targets include molecular regulators such as NCOR2, which modulates gene expression; NOS1, involved in nitric oxide production and OC function; and XIAP, which influences cell survival. Chromatin remodeling proteins like TACC2 and signaling pathways involving IRS1, MSX1, and AKT are also highlighted. The targets identified in this study are specific to polarized OCs and may not apply to non-polarized OCs or other cell types. These findings underscore the complexity of OC differentiation and function, enhancing our understanding of substrate-specific adaptations and suggesting new strategies for modulating bone metabolism and addressing bone-related disorders.

## Linked entities

- **Genes:** SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469], DHH (desert hedgehog signaling molecule) [NCBI Gene 50846], IHH (Indian hedgehog signaling molecule) [NCBI Gene 3549], SMO (smoothened, frizzled class receptor) [NCBI Gene 6608], NCOR2 (nuclear receptor corepressor 2) [NCBI Gene 9612], NOS1 (nitric oxide synthase 1) [NCBI Gene 4842], XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331], TACC2 (transforming acidic coiled-coil containing protein 2) [NCBI Gene 10579], IRS1 (insulin receptor substrate 1) [NCBI Gene 3667], MSX1 (msh homeobox 1) [NCBI Gene 4487], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** smoothened (smoothened protein), TACC2 (transforming acidic coiled-coil containing protein 2), IRS1 (insulin receptor substrate 1), MSX1 (msh homeobox 1), AKT1 (AKT serine/threonine kinase 1)

## Full-text entities

- **Genes:** NCOR2 (nuclear receptor corepressor 2) [NCBI Gene 9612] {aka CTG26, N-CoR2, SMAP270, SMRT, SMRTE, SMRTE-tau}, XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331] {aka API3, BIRC4, IAP-3, ILP1, MIHA, XLP2}, SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469] {aka HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC}, MSX1 (msh homeobox 1) [NCBI Gene 4487] {aka ECTD3, HOX7, HYD1, STHAG1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, IRS1 (insulin receptor substrate 1) [NCBI Gene 3667] {aka HIRS-1}, NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}, TACC2 (transforming acidic coiled-coil containing protein 2) [NCBI Gene 10579] {aka AZU-1, ECTACC}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IHH (Indian hedgehog signaling molecule) [NCBI Gene 3549] {aka BDA1, HHG2}, SMO (smoothened, frizzled class receptor) [NCBI Gene 6608] {aka CRJS, FZD11, Gx, PHLS, SMOH}, DHH (desert hedgehog signaling molecule) [NCBI Gene 50846] {aka GDMN, GDXYM, HHG-3, SRXY7}
- **Diseases:** bone-related disorders (MESH:D001847)
- **Chemicals:** nitric oxide (MESH:D009569)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12533897/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12533897/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12533897/full.md

---
Source: https://tomesphere.com/paper/PMC12533897